Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Kala Pharma Raises USD68 Million in Series C Financing Round 11
Kala Pharma Raises USD7 Million in Venture Financing 13
Kala Pharma Raises Us$22.5 Million In Series B Venture Financing 14
Kala Pharma Raises US$11.5 Million In Series A Financing 16
Kala Pharma Raises US$6.2 Million In Seed Financing 18
Equity Offering 19
Kala Pharma Raises USD71.2 Million in Public Offering of Shares 19
Kala Pharma Raises USD103.5 Million in IPO 21
Kala Pharmaceuticals Inc – Key Competitors 23
Kala Pharmaceuticals Inc – Key Employees 24
Kala Pharmaceuticals Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 09, 2018: Kala Pharmaceuticals reports second quarter 2018 financial results 26
Mar 26, 2018: Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results 28
Nov 07, 2017: Kala Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides Business Update 30
Corporate Communications 32
Mar 05, 2018: Kala Pharmaceuticals Names Gregory Perry As Board Director and as Audit Committee Chair 32
Nov 13, 2017: Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer 33
Oct 02, 2017: Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors 34
Product News 35
08/23/2018: Kala Pharmaceuticals announces FDA approval of INVELTYS for the treatment of post-operative inflammation and pain following ocular surgery 35
05/09/2018: Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launch 37
01/05/2018: Kala Pharmaceuticals Announces New Drug Application For Inveltys (KPI-121 1%) Has Been Accepted For Review By The U.S. Food And Drug Administration 38
Product Approvals 39
Oct 25, 2017: Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for INVELTYS (KPI-121 1%) 39
Clinical Trials 40
Jul 31, 2018: Kala Pharmaceuticals Announces Dosing of First Patient in Phase 3 STRIDE 3 Trial of KPI-121 0.25% in Patients with Dry Eye Disease 40
Jun 19, 2018: Kala Pharmaceuticals Announces Update to KPI-121 0.25% Development Plan 41
Apr 09, 2018: Kala Pharmaceuticals to Present at the 2018 American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) and at the Ophthalmology Innovation Summit at ASCRS 43
Jan 05, 2018: Kala Pharmaceuticals Announces Topline Results for Two Phase 3 Trials (STRIDE 1 and STRIDE 2) of KPI-121 0.25% in Dry Eye Disease 44
May 01, 2017: Kala Pharmaceuticals Announces Positive Results from Confirmatory Phase 3 Trial of KPI-121 1% Following Cataract Surgery 46
Jan 06, 2017: Kala Pharmaceuticals to Present Update on Phase 3 Programs at the 35th Annual J.P. Morgan Healthcare Conference 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kala Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kala Pharma Raises USD68 Million in Series C Financing Round 11
Kala Pharma Raises USD7 Million in Venture Financing 13
Kala Pharma Raises Us$22.5 Million In Series B Venture Financing 14
Kala Pharma Raises US$11.5 Million In Series A Financing 16
Kala Pharma Raises US$6.2 Million In Seed Financing 18
Kala Pharma Raises USD71.2 Million in Public Offering of Shares 19
Kala Pharma Raises USD103.5 Million in IPO 21
Kala Pharmaceuticals Inc, Key Competitors 23
Kala Pharmaceuticals Inc, Key Employees 24
Kala Pharmaceuticals Inc, Other Locations 25
List of Figures
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Kala Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer